Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)	Type1 Diabetes	Active, not recruiting	Phase 2	2025-10-03		NCT03782636

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Centre for Statistics in Medicine	1
Juvenile Diabetes Research Foundation	33
Oxford Clinical Trials Research Unit (OCTRU)	1
University of Oxford	213
Wellcome Trust	38

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Addenbrooke's Hospital	Cambridge	United Kingdom	26
Bristol Royal Hospital for Children	Bristol	United Kingdom	7
Nottingham Children's Hospital	Nottingham	United Kingdom	5
Oxford Children's Hospital	Oxford	United Kingdom	1
The Great North Children's Hospital	Newcastle upon Tyne	United Kingdom	1